When investing you have to do deep due diligence based on facts. There will always be information that you have no access to or you simply missed, that's where the risk comes from. Your speculations have no basis in any actual facts and trying to sell a pipe dream is a disservice to any stock because it raises false expectations. The facts - we know to an extent what the company is doing, we know the science shows what leronlimab can do, we also know it's going to be a grind before significant share price rise. The unexpected may happen but never count on it. The saving grace for this stock is the huge potential.